MUHC in the News - June 3, 2019

Dr. Ivan Litvinov

New study finds ‘strikingly high’ rates of cancer in Ontario industrial cities

MUHC dermatologist Dr. Ivan Litvinov speaks with Global TV about a new study from the Research Institute of the MUHC that shows living in industrial cities may increase your chance of getting cancer.

 

Guidelines for managing anaphylaxis in children need an update

Guidelines for managing anaphylaxis in children need an update

Dr. Moshe Ben-Shoshan, allergist and immunologist at the MCH and RI-MUHC, speaks to The Gazette, La Presse Canadienne and TVA about new study findings showing that pre-hospital treatment with epinephrine has the highest protective effect against uncontrolled allergic reaction. Sofianne Gabrielli, first author of the study, speaks to the CBC 88.5 f.m.

 ​

Dr. Paul Giacomini

Multiple sclerosis research

Dr. Paul Giacomini from The Neuro talks about the most recent advances in multiple sclerosis research and the reasons why it touches so many people in Canada. CTV

 

Dr. Erwan Pernet and Dr. Maziar Divangahi

On promising path towards developing flu treatment using lipid target

Dr. Erwan Pernet and Dr. Maziar Divangahi, along with their colleagues at the Research Institute of the MUHC, have identified a lipid target to “tone down” the hyper-active immunity to influenza infection. Dr. Pernet speaks to Radio-Canada International, Radio-Canada Science, Medicine Newsline, Science Daily, and Eurek Alert.